Home › Psychomotor Agitation
Psychomotor Agitation clinical trials recruiting in the U.S.
9 studies for Psychomotor Agitation are recruiting participants at sites across the United States.
Cities with the most studies
- Miami, FL5 studies
- Tampa, FL4 studies
- Orlando, FL3 studies
- Atlanta, GA3 studies
- Deltona, FL3 studies
- Cypress, TX3 studies
- St. Petersburg, FL3 studies
By state
- Arizona3 studies
- California4 studies
- Florida6 studies
- Georgia3 studies
- Massachusetts3 studies
- New Jersey3 studies
- New York5 studies
- North Carolina3 studies
- Ohio3 studies
- Oklahoma3 studies
- Texas4 studies
Recently updated studies
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 28, 2026 · NCT06937229Neurosteer Bedside Monitoring System
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06718764Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
RecruitingPhase 2
All ages · All sexes · Updated Sep 16, 2026 · NCT06052254A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 16, 2026 · NCT07011745Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients
RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Jun 22, 2026 · NCT07649876Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated May 28, 2026 · NCT06781333Clinical Trial on Agitation in Alzheimer's Dementia
RecruitingPhase 2
Ages 60 and older · All sexes · Updated May 20, 2026 · NCT05543681Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
RecruitingPhase 2
Ages 50 to 90 · All sexes · Updated Feb 16, 2023 · NCT04436081From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.